Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants
© 2021, Jaworski et al..
High-throughput genomics of SARS-CoV-2 is essential to characterize virus evolution and to identify adaptations that affect pathogenicity or transmission. While single-nucleotide variations (SNVs) are commonly considered as driving virus adaption, RNA recombination events that delete or insert nucleic acid sequences are also critical. Whole genome targeting sequencing of SARS-CoV-2 is typically achieved using pairs of primers to generate cDNA amplicons suitable for next-generation sequencing (NGS). However, paired-primer approaches impose constraints on where primers can be designed, how many amplicons are synthesized and requires multiple PCR reactions with non-overlapping primer pools. This imparts sensitivity to underlying SNVs and fails to resolve RNA recombination junctions that are not flanked by primer pairs. To address these limitations, we have designed an approach called 'Tiled-ClickSeq', which uses hundreds of tiled-primers spaced evenly along the virus genome in a single reverse-transcription reaction. The other end of the cDNA amplicon is generated by azido-nucleotides that stochastically terminate cDNA synthesis, removing the need for a paired-primer. A sequencing adaptor containing a Unique Molecular Identifier (UMI) is appended to the cDNA fragment using click-chemistry and a PCR reaction generates a final NGS library. Tiled-ClickSeq provides complete genome coverage, including the 5'UTR, at high depth and specificity to the virus on both Illumina and Nanopore NGS platforms. Here, we analyze multiple SARS-CoV-2 isolates and clinical samples to simultaneously characterize minority variants, sub-genomic mRNAs (sgmRNAs), structural variants (SVs) and D-RNAs. Tiled-ClickSeq therefore provides a convenient and robust platform for SARS-CoV-2 genomics that captures the full range of RNA species in a single, simple assay.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
eLife - 10(2021) vom: 28. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jaworski, Elizabeth [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.10.2021 Date Revised 01.04.2022 published: Electronic SRA: PRJNA707211 UpdateOf: bioRxiv. 2021 Sep 01;:. - PMID 33758846 Citation Status MEDLINE |
|---|
| doi: |
10.7554/eLife.68479 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331232529 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331232529 | ||
| 003 | DE-627 | ||
| 005 | 20231225213018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7554/eLife.68479 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM331232529 | ||
| 035 | |a (NLM)34581669 | ||
| 035 | |a (PII)e68479 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jaworski, Elizabeth |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.10.2021 | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a SRA: PRJNA707211 | ||
| 500 | |a UpdateOf: bioRxiv. 2021 Sep 01;:. - PMID 33758846 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021, Jaworski et al. | ||
| 520 | |a High-throughput genomics of SARS-CoV-2 is essential to characterize virus evolution and to identify adaptations that affect pathogenicity or transmission. While single-nucleotide variations (SNVs) are commonly considered as driving virus adaption, RNA recombination events that delete or insert nucleic acid sequences are also critical. Whole genome targeting sequencing of SARS-CoV-2 is typically achieved using pairs of primers to generate cDNA amplicons suitable for next-generation sequencing (NGS). However, paired-primer approaches impose constraints on where primers can be designed, how many amplicons are synthesized and requires multiple PCR reactions with non-overlapping primer pools. This imparts sensitivity to underlying SNVs and fails to resolve RNA recombination junctions that are not flanked by primer pairs. To address these limitations, we have designed an approach called 'Tiled-ClickSeq', which uses hundreds of tiled-primers spaced evenly along the virus genome in a single reverse-transcription reaction. The other end of the cDNA amplicon is generated by azido-nucleotides that stochastically terminate cDNA synthesis, removing the need for a paired-primer. A sequencing adaptor containing a Unique Molecular Identifier (UMI) is appended to the cDNA fragment using click-chemistry and a PCR reaction generates a final NGS library. Tiled-ClickSeq provides complete genome coverage, including the 5'UTR, at high depth and specificity to the virus on both Illumina and Nanopore NGS platforms. Here, we analyze multiple SARS-CoV-2 isolates and clinical samples to simultaneously characterize minority variants, sub-genomic mRNAs (sgmRNAs), structural variants (SVs) and D-RNAs. Tiled-ClickSeq therefore provides a convenient and robust platform for SARS-CoV-2 genomics that captures the full range of RNA species in a single, simple assay | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
| 650 | 4 | |a ClickSeq | |
| 650 | 4 | |a Defective RNAs | |
| 650 | 4 | |a Genomics | |
| 650 | 4 | |a Nanopore Sequencing | |
| 650 | 4 | |a Next-Generation Sequencing | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a infectious disease | |
| 650 | 4 | |a microbiology | |
| 650 | 4 | |a viruses | |
| 650 | 7 | |a DNA, Complementary |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 650 | 7 | |a RNA, recombinant |2 NLM | |
| 650 | 7 | |a RNA |2 NLM | |
| 650 | 7 | |a 63231-63-0 |2 NLM | |
| 700 | 1 | |a Langsjoen, Rose M |e verfasserin |4 aut | |
| 700 | 1 | |a Mitchell, Brooke |e verfasserin |4 aut | |
| 700 | 1 | |a Judy, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Newman, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Plante, Jessica A |e verfasserin |4 aut | |
| 700 | 1 | |a Plante, Kenneth S |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Aaron L |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yiyang |e verfasserin |4 aut | |
| 700 | 1 | |a Swetnam, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Sotcheff, Stephanea |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Saada, Nehad |e verfasserin |4 aut | |
| 700 | 1 | |a Machado, Rafael Rg |e verfasserin |4 aut | |
| 700 | 1 | |a McConnell, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a Widen, Steven G |e verfasserin |4 aut | |
| 700 | 1 | |a Thompson, Jill |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Jianli |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Pyles, Rick B |e verfasserin |4 aut | |
| 700 | 1 | |a Ksiazek, Thomas G |e verfasserin |4 aut | |
| 700 | 1 | |a Menachery, Vineet D |e verfasserin |4 aut | |
| 700 | 1 | |a Weaver, Scott C |e verfasserin |4 aut | |
| 700 | 1 | |a Routh, Andrew L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 10(2021) vom: 28. Sept. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g day:28 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.68479 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |b 28 |c 09 | ||